Distance Learning Courses: BRCU Online 2010

Dear Colleagues,

Welcome to BRCU Online, a great way to review what you already know as well as information you just learned at the Board Review Course & Update 2010 live course. For those of you who did not attend the live course, BRCU Online is a close approximation to the comprehensive review and update of nephrology that took place in San Francisco. BRCU Online is not only for those preparing for initial certification and maintenance of certification (MOC), but for practicing nephrologists simply wanting an update in nephrology and its related disorders.

The program flows smoothly, is characterized by a blend of didactic lectures and interactive problem-solving workshops focused on board review material as well as current, cutting-edge, and controversial update topics. A diverse faculty, widely recognized for their expertise in their subject matter and their presentation skills, is the real highlight of the BRCU 2010—so, again I welcome you to log on for this outstanding experience.

John M. Burkart, MD

ASN BRCU 2010 Online

ASN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ASN designates this educational activity for a maximum of 64.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Course Description

The ASN Board Review Course & Update (BRCU) is the primary preparatory course for the ABIM's initial certification and maintenance of certification examinations in nephrology and is the premier comprehensive update for the practicing nephrologist. Each BRCU topic section and its applicable time allocation are patterned after the ABIM nephrology examination blueprint.

Learn more with this informational video.

BRCU Education Directors

John M. Burkart, MD
Marc A. Pohl, MD

Original Release Date

October 2010

CME and Exam Termination Date

August 12, 2011

Estimated Time to Complete BRCU Online

65 Hours

CME credit will be posted to your ASN transcript within 24 hours of completion of the online attestation and evaluation.

The ASN BRCU practice final examination can be taken on the ASN CME Center site. Participants can print their score, the correct answers, and explanations upon completion of the examination.

Learning Objectives

After completing the ASN Board Review Course & Update, participants can:

  • Interpret fundamental concepts of kidney function/structure, fluid and electrolytes, glomerular/vascular disorders, tubulointerstitial disorders, bone and mineral metabolism, stones, hypertension, AKI and ICU nephrology, CKD, ESRD, and dialysis, and transplantation;
  • Identify the best diagnostic and therapeutic options for patients with kidney disease; and
  • Test individual medical practice competence against a series of simulated case scenarios.

Lectures Included

  • Acid Base Disorders: Basic Physiology, Definitions, and Compensation
    Thomas D. DuBose, Jr., MD, FASN
  • Acute and Chronic Interstitial Diseases
    Gerald B. Appel, MD, FASN
  • Acute Kidney Injury: Pathogenesis, Diagnosis, Biomarkers and Risk Assessment
    Charuhas V. Thakar, MD
  • Acute Kidney Injury: Prevention and Non-Dialytic Therapy
    Paul M. Palevsky, MD, FASN
  • Acute Renal Replacement Therapies
    Ashita J. Tolwani, MD
  • Calcium, Phosphorus, PTH, and Vitamin D: Key Physiologic Principles
    Zalman S. Agus, MD
  • Case Discussions I: Electrolyte and Acid Base Emergencies in the ICU
    Michael Emmett, MD, Asghar Rastegar, MD
  • Case Discussions I: Volume, Sodium, and Water Disorders
    Tomas Berl, MD, FASN, Richard H. Sterns, MD, John B. Stokes, III, MD, FASN
  • Case Discussions II: Acid-Base and Potassium Disorders
    Thomas D. DuBose, Jr., MD, FASN, Michael Emmett, MD, Asghar Rastegar, MD
  • Case Discussions II: Volume, Sodium, and Water Disorders
    Tomas Berl, MD, FASN, Richard H. Sterns, MD, John B. Stokes, III, MD, FASN
  • Case Discussions: Acute Kidney Injury, Hepatorenal Syndrome, Cardiorenal Syndrome and ICU Nephrology
    Paul Palevsky, Charuhas Thakar, Ashita Tolwani
  • Case Discussions: Infectious Complications of Peritoneal Dialysis
    Beth M. Piraino, MD
  • Case-Based Workshop for Bone and Mineral Metabolism
    Zalman S. Agus, MD, David A. Bushinsky, MD, Stuart M. Sprague, DO, FASN
  • Cystic Diseases
    William M. Bennett, MD, FASN
  • Diabetic Nephropathy
    Julia Lewis, MD
  • Dialysis: Basic Principles, Diffusion, Convection, Ultrafiltration
    Thomas A. Depner, MD
  • Disorders of Calcium and Phosphorous
    David A. Bushinsky, MD
  • Disorders of Volume and Sodium Regulation: Edema, Hypovolemia, Hypervolemia, Hypotonic and Hypertonic States
    John B. Stokes, III, MD, FASN
  • Drug Induced HTN
    Raymond R. Townsend, MD
  • Drug Intoxications
    Paul M. Palevsky, MD, FASN
  • Dysproteinemias, Amyloid, Fibrillary Glomerulonephritis, and Thrombotic Angiopathies
    Gerald B. Appel, MD, FASN
  • Evaluation of a Potential Transplant Recipient
    Donald E. Hricik, MD
  • Evaluation of the Living Donor
    Stephen J. Tomlanovich, MD
  • GFR, Performance Equations, Monitoring Progression of CKD, and Interpretation of Proteinuria, Albuminuria, and the Urinary Sediment
    Richard J. Glassock, MD
  • Hemodialysis: Access Issues, Thrombosis, Stenosis and Infections
    Charmaine E. Lok, MD
  • Hemodialysis: Adequacy Issues (including Home HD)
    Thomas A. Depner, MD
  • Hemodialysis: Blood Pressure, Volume Control, and Cardiovascular Comorbidities
    William L. Henrich, MD, FASN
  • Herbs, NSAIDs, and Heavy Metals: A Recipe for Kidney Failure
    Warren L. Kupin, MD
  • Hypertensive Urgencies and Emergencies: Clinical Presentations and Therapy
    Raymond R. Townsend, MD
  • Idiopathic or Primary Glomerulonephritides
    Stephen M. Korbet, MD, FASN
  • Imaging the Kidney and Urinary Tract and Urologic Conditions that the Nephrologist Must Know
    Marshall L. Stoller, MD
  • Increased Anion Gap Metabolic Acidosis
    Michael Emmett, MD
  • Magnesium: Normal Physiology, Hypomagnesemia, and Hypermagnesemia
    Zalman S. Agus, MD
  • Management of Selected Issues in Patients with CKD: What You Should Be Doing in Your CKD Clinic
    Jerry Yee, MD, FASN
  • Medical and Immunosuppressive Management: Case Based Approach
    William M. Bennett, MD, FASN, Douglas J. Norman, MD
  • Metabolic Alkalosis
    Thomas D. DuBose, Jr., MD, FASN
  • Nephrolithiasis: Pathogenesis, Diagnosis, and Treatment
    David A. Bushinsky, MD, Marshall L. Stoller, MD
  • Non Anion Gap Metabolic Acidosis
    Thomas D. DuBose, Jr., MD, FASN
  • Panel Discussion: How to Treat Refractory Glomerular Diseases
    Stephen M. Korbet, MD, FASN, Richard J. Glassock, MD, Ronald J. Falk, MD, FASN, Gerald B. Appel, MD, FASN
  • Pathogenesis of Metabolic Bone Diseases
    Stuart M. Sprague, DO, FASN
  • Pathology of Glomerulonephritides
    Helmut G. Rennke, MD
  • Pathophysiology and Treatment of Essential Hypertension
    Phyllis August, MD
  • Peritoneal Dialysis: Adequacy Issues
    Beth M. Piraino, MD
  • Peritoneal Dialysis: Physiology and Approach to the Volume Overloaded Patient
    John M. Burkart, MD
  • Post Transplant Infectious Complications
    Ajit Limaye, MD
  • Post Transplant Non-Infectious Complications: Rejection, Metabolic, and Surgical
    Donald E. Hricik, MD
  • Potassium: Key Physiologic Principles, Hypokalemia, and Hyperkalemia
    Michael Emmett, MD
  • Pregnancy: Hypertension and Kidney Disease
    Phyllis August, MD
  • Principles of Drug Prescribing in Acute and Chronic Kidney Disease
    William M. Bennett, MD, FASN
  • Principles of Hypernatremia
    Tomas Berl, MD, FASN
  • Principles of Hyponatremia
    Richard H. Sterns, MD
  • Principles of Transplant Immunobiology: HLA Matching and Mechanisms of Immunosuppressive Drugs
    Douglas J. Norman, MD
  • Renal Artery Stenosis, Renovascular Hypertension, and Ischemic Nephropathy
    Marc A. Pohl, MD
  • Renal Biopsy Case-Based Workshop
    Gerald B. Appel, MD, FASN, Agnes B. Fogo, MD, Richard J. Glassock, MD, Stephen M. Korbet, MD, FASN, Julia Lewis, MD, Helmut G. Rennke, MD
  • Respiratory Acidosis and Alkalosis
    Asghar Rastegar, MD
  • Secondary Glomerulonephritides and Vasculitis
    Ronald J. Falk, MD, FASN
  • Secondary Hypertension: Clinical Syndromes, Diagnostic Workup, and Management
    Raymond R. Townsend, MD
  • Selective Genetic Diseases of the Kidney
    Agnes B. Fogo, MD
  • The Transplant Biopsy: Indications and Findings
    Jean L. Olson, MD
  • Treatment Options for Patients with Metabolic Bone Diseases
    Stuart M. Sprague, DO, FASN
  • Viral Nephridities, including HIV, CMV, and Hepatitis
    Warren L. Kupin, MD
  • Welcome & Introduction
    Marc A. Pohl, MD

Target Audience

**Senior Nephrologists: Practicing nephrologists in all key areas. The course also benefits pediatric nephrologists, intensivists, and hospitalists.

Board Examination Participants: Physicians taking board and MOC exams who want to improve their ability to do well on these exams.

Renal Fellows: Fellows seeking a comprehensive outline of what their current fellowship program should include.

**Fellow of the American Society of Nephrology (FASN) status: The 64.75 CME credit hours earned at the BRCU can be applied towards the 70 hours required biennially to qualify for FASN status.

Statement from ABIM

This course was developed as an original and independent educational offering based on the public ABIM examination blueprint and is not approved or endorsed by ABIM. In accordance with ABIM policy, no ABIM Board members have been involved in the development of this course. ASN cannot guarantee that attending this course will result in passing the ABIM examination.

Course Faculty List/Disclosure

Internationally renowned speakers were selected for their expert teaching skills and highly rated past performances in this and similar courses. Included in this esteemed faculty are current and former ASN Presidents and Councilors and former members of the ABIM Subspecialty Board on Nephrology.

BRCU Course Faculty List

  • Zalman S. Agus, MD
  • Gerald B. Appel, MD, FASN
  • Phyllis August, MD
  • William M. Bennett, MD, FASN
  • Tomas Berl, MD, FASN
  • John M. Burkart, MD
  • David A. Bushinsky, MD
  • William G. Couser, MD, FASN
  • Thomas A. Depner, MD
  • Thomas D. DuBose, MD, FASN
  • Michael Emmett, MD
  • Ronald J. Falk, MD, FASN
  • Agnes B. Fogo, MD
  • Richard J. Glassock, MD
  • William L. Henrich, MD, FASN
  • Donald E. Hricik, MD
  • Stephen M. Korbet, MD, FASN
  • Warren L. Kupin, MD
  • Julia Lewis, MD
  • Ajit Limaye, MD
  • Charmaine E. Lok, MD
  • Douglas J. Norman, MD
  • Jean L. Olson, MD
  • Paul M. Palevsky, MD, FASN
  • Beth M. Piraino, MD
  • Marc A. Pohl, MD
  • Asghar Rastegar, MD
  • Helmut G. Rennke, MD
  • Stuart M. Sprague, DO, FASN
  • Richard H. Sterns, MD
  • John B. Stokes, MD, FASN
  • Marshall L. Stoller, MD
  • Charuhas V. Thakar, MD
  • Ashita J. Tolwani, MD
  • Stephen J. Tomlanovich, MD
  • Raymond R. Townsend, MD
  • Jerry Yee, MD, FASN

Faculty and Planner Disclosure Statements

Agus, Zalman - NO, neither I nor my spouse/partner have anything to disclose.

Appel, Gerald - Consultancy Agreements: Amgen, AMAG, Ortho, Centocor, Questcor, Roche, Genentech, Vifor, Pfizer, Genzyme; Research Funding: Vifor-Aspreva, Genentech, Questcor, Novartis; Honoraria: Amgen, Ortho, Centocor, Pfizer, Takeda, Merck; Scientific Advisor or Membership: Amgen, Genzyme, Centocore, Amag.

August, Phyllis - NO, neither I nor my spouse/partner have anything to disclose.

Bennett, William - NO, neither I nor my spouse/partner have anything to disclose.

Berl, Tomas – Current Employer: University of Colorado Denver; Consultancy Agreements: Astra- Zeneca, BMS, Otsuka; Honoraria: Otsuka; Scientific Advisor or Membership: Otsuka.

Burkart, John – Current Employer: Wake Forest University Health Systems Management; Honoraria: Fresenius, Davita, Baxter, RRI, ASN; Scientific Advisor or Membership: Ad hoc per day with: Baxter, NxStage, AMGEN, Genzyme; Any other interests/relationships: Unrestricted educational grants to ISPD or Wake Forest for PDU's from: Baxter, Nxstage, AMAG, Genzyme, Davita, Abbott.

Bushinsky, David – Current Employer: University of Rochester School of Medicine; Consultancy Agreements: Amgen, Genzyme, Cytochroma, Relypsa; Ownership Agreement: Amgen, Relypsa; Honoraria: Amgen, Genzyme, Cytochroma, Relypsa; Scientific Advisor or Membership: Amgen, Genzyme,Cytochroma, Relypsa.

Couser, William – Consultancy Agreements: Questcor, Sanofi-Aventis; Honoraria: $3000

Depner, Thomas - NO, neither I nor my spouse/partner have anything to disclose.

DuBose, Thomas - NO, neither I nor my spouse/partner have anything to disclose.

Emmett, Michael - NO, neither I nor my spouse/partner have anything to disclose.

Falk, Ronald - NO, neither I nor my spouse/partner have anything to disclose.

Fogo, Agnes - Consultancy Agreements: Abbott, Genzyme, Takeda, Boehringer Ingelheim, Wyeth; Research Funding: Takeda, Boehringer Ingelheim, Roche; Honoraria: Abbott, Genzyme, BoehringerIngelheim, Wyeth; Scientific Advisory or Membership: Genzyme Renal Innovations Program Grant Review Committee.

Glassock, Richard – Consultancy Agreements: Aspreva, FibroGen, Genentech, Bristol-Myers-Squibb, BioMarin, Wyeth, Eli Lilly, Novartis, Gilead Sciences, QuestCor, UpToDate, Lighthouse Learning; Ownership Interest: La Jolla Pharm, Reata; Honoraria: Various Lectures- $20,000, UpToDate; Patent and Inventions: None, other than Book Royalties; Scientific Advisor or Membership: LosAngeles Biomedical Institute; University Kidney Research Organization (Board of Directors); NephSAP (Editorial Board); Nephron: Clinical Practice (Editorial Board).

Henrich, William - NO, neither I nor my spouse/partner have anything to disclose.

Hricik, Donald - NO, neither I nor my spouse/partner have anything to disclose.

Korbet, Stephen - NO, neither I nor my spouse/partner have anything to disclose.

Kupin, Warren - NO, neither I nor my spouse/partner have anything to disclose.

Lewis, Julia – Research Funding: Keryx, Nephrogenix,Lilly, Celexa.

Limaye, Ajit – Consultancy Agreement: Genentech, Vical, Viropharma; Research Funding: Roche, Viropharma; Honoraria: Roche, Genentech, Amgen, Novartis, Vical.

Lok, Charmaine - NO, neither I nor my spouse/partner have anything to disclose.

Norman, Douglas - NO, neither I nor my spouse/partner have anything to disclose.

Olson, Jean - NO, neither I nor my spouse/partner have anything to disclose.

Palevsky, Paul – Consultancy Agreements: CytoPheryx, Inc.; Research Funding: Spectral Diagnostics, Inc.

Piraino, Beth - NO, neither I nor my spouse/partner have anything to disclose.

Pohl, Marc - NO, neither I nor my spouse/partner have anything to disclose.

Rasteger, Asghar - NO, neither I nor my spouse/partner have anything to disclose.

Rennke, Helmut - NO, neither I nor my spouse/partner have anything to disclose.

Sprague, Stuart – Consultancy Agreements: Abbott, Amgen, Ineos, Shire; Research Funding: Abbott, Amgen, Ineos, Mitsubishi, Shire.

Sterns, Richard - Honoraria: Otsuka, Astellas, Merck. Scientific Advisory or Membership: Merck (Renal Safety Committee).

Stokes, John - NO, neither I nor my spouse/partner have anything to disclose.

Stoller, Marshall - NO, neither I nor my spouse/partner have anything to disclose.

Thakar, Charuhas - NO, neither I nor my spouse/partner have anything to disclose.

Tolwani, Ashita - NO, neither I nor my spouse/partner have anything to disclose.

Tomlanovich, Stephen - NO, neither I nor my spouse/partner have anything to disclose.

Townsend, Raymond – Consultancy Agreements: Roche, GSK, Novartis, Nicox; Research Funding: NIH, Novartis; Honoraria: Merck, Takeda, ASN, ASH; Patent and Inventions: UpToDate; Scientific Advisor or Membership: Journal of Clinical Hypertension (Editorial Board).

Yee, Jerry – Consultancy Agreement: Amgen, Affymax; Ownership Interest: Merck; Research Funding: Fresenius; Honoraria: Takeda/Affymax, Merck, Amgen, Watson, Genzyme; Patent and Inventions: VascAlert; Scientific Advisor or Membership: American Journal of Nephrology (Editorial Staff); Advances in Chronic Kidney Disease (Editor-in-Chief); Any Other Interests/Relationships: Co-inventor of Regional Citrate Anticoagulation Technology (Patent Pending); author of a CKD Book, with copyright by Henry Ford Health System.

Staff Disclosure Statements

The following ASN staff do not have anything to disclose:

Cara Hill
Angela Kim
Jin Soo Kim
Phillip Kokemueller
Ryan Russell
Alisha Graham
Jessica Zvara

All disclosure information as of 7/23/2010.

Faculty, Planner, and Staff Disclosure

It is the policy of American Society of Nephrology (ASN) that all individuals in a position to control the content of ASN's sponsored CME activities are expected to provide full disclosure for both themselves and their spouse/partner, and indicate to the program audience any financial or other relationship held by themselves or their spouse/partner 1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial service(s) discussed in an educational presentation; and 2) with any commercial supporter(s) of the activity. All responses should reflect activities within the previous 12 months. This disclosure information is collected in accordance with Accreditation Council for Continuing Medical Education (ACCME). Furthermore, ASN requires all faculty to disclose at the time of their lecture, any planned discussion of investigational and/or off-label use of pharmaceutical products or devices within their presentation. Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in Continuing Medical Education (CME), but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

ASN requires all individuals in a position to control content for the ASN Board Review Course & Update 2010 (August 28 – September 3, 2010, in San Francisco, California) to complete faculty disclosure forms on ASN's “Subject Matter Expert” website. Responses are listed below.

View the full ASN Conflict of Interest and Disclosure Policy.

Hardware/Software Requirements

Computers

Any computer running Windows, Mac OS, or Unix machines are supported.

Medium or Combination of Media Used

Streaming media video of slides with audio

System Requirements

For a successful viewing experience, the following hardware and software are required:

  • Broadband cable, DSL or high-speed Internet connection
  • Internet Explorer version 7 or higher or equivalent modern browser
  • 533 MHz or faster processor
  • At least 512 MB RAM
  • Adobe Reader 9.3
  • Adobe Flash Player v. 9 or higher

Method of Participation

  • Listen and view the streaming media with slides.
  • Complete the practice examination.
  • Your scores, answers, and explanations are available for print immediately. Review answer key.
  • Complete the CME evaluation.

Prices

ASN Fellow-in-Training Member = $975
ASN Member = $1,200
Nonmember = $1,450
Nonmember Fellow-in-Training = $1,150

Refund Policy

All sales are final.

Privacy Policy/Confidentiality

As a condition of your access and use of the Website, you agree not to use the Website for any purpose that is unlawful or inconsistent with the Agreement. ASN, in its sole discretion, is authorized to remove or delete any entries, information, materials, or other content that violates these Terms of Use or that is otherwise objectionable. ASN reserves the right to investigate and prosecute violations of any of these Terms of Use to the fullest extent of the law. If Users fail to comply with these Terms of Use, ASN in its sole discretion may terminate the User's access to the website immediately without advance notice. These terms of use comprise an Agreement that is governed by the laws of the District of Columbia, which shall be the forum for any disputes.

Commercial Support

The ASN Board Review Course & Update live activity and online enduring materials are supported by educational grants from the following companies:

Contact Information

For assistance, please contact ASN at education@asn-online.org or call 202-659-0599.

Additional Information

Please review the following information:

Access Your Subscription